These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3214766)

  • 1. Project of experimental bioassays on chemoprevention agents performed at the Bologna Institute of Oncology: report on tamoxifen control of spontaneous mammary tumors on Sprague-Dawley rats.
    Maltoni C; Pinto C; Paladini G
    Cancer Invest; 1988; 6(5):643-58. PubMed ID: 3214766
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of an estrogen antagonist (tamoxifen) on the initiation and progression of gamma-irradiation-induced mammary tumors in female Sprague-Dawley rats.
    Welsch CW; Goodrich-Smith M; Brown CK; Miglorie N; Clifton KH
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1255-8. PubMed ID: 7200024
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of L-arginine on growth of rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
    Takeda Y; Tominaga T; Tei N; Kitamura M; Taga S
    Cancer Res; 1975 Sep; 35(9):2390-3. PubMed ID: 807324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model.
    Peterson NC; Servinsky MD; Christian A; Peng Z; Qiu W; Mann J; Dicello J; Huso DL
    Carcinogenesis; 2005 Sep; 26(9):1542-52. PubMed ID: 15860508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
    Fendl KC; Zimniski SJ
    Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine inhibits development of benign mammary gland tumors in carcinogen-treated female Sprague-Dawley rats.
    Wolfrom DM; Rao AR; Welsch CW
    Breast Cancer Res Treat; 1991 Nov; 19(3):269-75. PubMed ID: 1777646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.
    Jordan VC
    Cancer Invest; 1988; 6(5):589-95. PubMed ID: 3063338
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrous cycle and ovarian changes in a rat mammary carcinogenesis model after irradiation, tamoxifen chemoprevention, and aging.
    Karim BO; Landolfi JA; Christian A; Ricart-Arbona R; Qiu W; McAlonis M; Eyabi PO; Khan KA; Dicello JF; Mann JF; Huso DL
    Comp Med; 2003 Oct; 53(5):532-8. PubMed ID: 14655997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
    Iino Y; Takai Y; Sugamata N; Morishita Y
    Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of three life-span experimental carcinogenicity and anticarcinogenicity studies on tamoxifen in rats.
    Maltoni C; Minardi F; Pinto C; Belpoggi F; Bua L
    Ann N Y Acad Sci; 1997 Dec; 837():469-512. PubMed ID: 9472359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.
    Gotoh T; Yamada K; Ito A; Yin H; Kataoka T; Dohi K
    Jpn J Cancer Res; 1998 May; 89(5):487-95. PubMed ID: 9685851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A; Shilkaitis A; Christov K
    Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen.
    Hollingsworth AB; Lerner MR; Lightfoot SA; Wilkerson KB; Hanas JS; McCay PB; Brackett DJ
    Breast Cancer Res Treat; 1998 Jan; 47(1):63-70. PubMed ID: 9493977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model.
    Ménard S; Aiello P; Tagliabue E; Rumio C; Lollini PL; Colnaghi MI; Balsari A
    Cancer Res; 2000 Jan; 60(2):273-5. PubMed ID: 10667575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoid-tamoxifen interaction in mammary cancer chemoprevention.
    McCormick DL; Moon RC
    Carcinogenesis; 1986 Feb; 7(2):193-6. PubMed ID: 2936526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICI 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison.
    Welsch CW; Goodrich-Smith M; Brown CK; Mackie D; Johnson D
    Oncology; 1982; 39(2):88-92. PubMed ID: 6801566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours.
    Constantinou AI; White BE; Tonetti D; Yang Y; Liang W; Li W; van Breemen RB
    Eur J Cancer; 2005 Mar; 41(4):647-54. PubMed ID: 15737570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prenatal and prepubertal genistein exposure on N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats.
    Pei RJ; Sato M; Yuri T; Danbara N; Nikaido Y; Tsubura A
    In Vivo; 2003; 17(4):349-57. PubMed ID: 12929590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of retinoic acid (RA) in MNU-induced rat mammary tumors.
    Okamoto T; Fujimoto N; Gotoh T; Ito A
    Ann N Y Acad Sci; 1995 Sep; 768():223-6. PubMed ID: 8526352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.